Introduction {#s1}
============

Although genome wide association studies (GWAS) have considerably advanced our knowledge of the genetics of complex traits, they fail to account for the bulk of the overall heritability [@pgen.1001292-Manolio1]. Structural variation, including copy number variants (CNVs), may account for some of the missing heritability, but a comprehensive study of the contribution of these variants to complex traits genetics is generally lacking. One of the main challenges of integrating CNVs into GWAS is the reliability of their assay, but improvements in genotyping platforms and the development of algorithms for the analysis of CNVs increasingly facilitate the investigation of the role of CNVs in disease susceptibility [@pgen.1001292-McCarroll1]. Given the effect of adjacent CNVs on SNP intensity data, early SNP arrays were designed with the consequence that assays from many CNV loci were excluded, but a newer generation of arrays have been implemented that combine SNP assays and copy number probes optimized for copy-number measurement for target regions of known CNVs [@pgen.1001292-McCarroll2]. New algorithms are also facilitating higher resolution maps of common CNVs (those that segregate at an allele frequency \>5%).

Partly due to these technological and analytic developments, the search for links between CNVs and disease susceptibility has been actively pursued in recent years. Structural variation has of course long been known to influence such Mendelian disorders as Williams-Beuren syndrome or Charcot-Marie Tooth neuropathy Type 1A, but more recently there has been widespread interest in the study of CNVs as mediators of more common complex diseases. The contribution of structural variation to certain neurodevelopmental disorders such as schizophrenia and autism spectrum disorder has been investigated by recent studies of *de novo* copy number variation [@pgen.1001292-Walsh1]. A common 20 kb deletion upstream of *IRGM* in perfect linkage disequilibrium (*r^2^* = 1.0) with the SNP most strongly associated with Crohn\'s disease in the region has recently been shown to alter *IRGM* regulation, which in turn is known to affect autophagy, consistent with the deletion polymorphism being the causal allele [@pgen.1001292-McCarroll3]. Similarly, a 45 kb deletion polymorphism in *NEGR1* has been shown to be the likely causal variant for the reproducible association with body mass index in humans, demonstrating a neuronal influence on body weight regulation [@pgen.1001292-Willer1]. These discoveries and similar developments suggest that the interpretation of known disease associations continues to be fraught with challenges, as CNVs may be in linkage disequilibrium (LD) with associated variants, and that the identification of causal variants requires an approach that considers both SNPs and CNVs at associated loci.

The recent release [@pgen.1001292-Conrad1] of a reference map of human CNVs in the HapMap populations promises to shed light on the role of these variants in disease pathogenesis. On the other hand, a recent comprehensive study [@pgen.1001292-WTCCC1] involving 16,000 cases of eight common diseases and 3000 shared controls strongly suggests that CNVs are likely to make a relatively minor contribution to disease susceptibility. In the present study, we approached the investigation of this important topic by exploring evidence of enrichment of CNVs among trait-associated loci in disease susceptibility and in disease classes, as represented by the NHGRI catalog of reproducible associations from genome-wide association scans [@pgen.1001292-Hindorff1], for certain classes of CNVs, and by conducting a comprehensive functional characterization of CNVs as expression quantitative trait loci (eQTLs). The former seeks to evaluate the genetic information contained in CNVs in regard to disease risk and other complex traits; the latter assesses the functional impact of CNVs on the transcriptome, through which they may contribute to or cause disease phenotypes and other complex traits [@pgen.1001292-Nicolae1].

Results {#s2}
=======

Tagged CNVs (tCNVs) are enriched for eQTLs and *cis*-acting eQTLs {#s2a}
-----------------------------------------------------------------

[Table 1](#pgen-1001292-t001){ref-type="table"} summarizes the CNVs included in our study. Because of the ease with which SNPs can be utilized in enrichment studies appropriately conditioned on minor allele frequency, we utilized tCNVs (CNVs tagged by SNPs) for many of these studies, but did not otherwise consider them to be a special class of CNVs.

10.1371/journal.pgen.1001292.t001

###### CNV categories that were investigated for role in transcriptional expression.

![](pgen.1001292.t001){#pgen-1001292-t001-1}

  *CNV Category*                                                        *Count*
  -------------------------------------------------------------------- ---------
  Well-tagged CNVs (*r^2^*≥0.80) in WTCCC study                          1761
  Remaining CNVs (*r^2^*\<0.80) in WTCCC study                           1671
  Non-WTCCC CNVs assayed in HapMap cell lines included in this study     1503

Three classes of CNVs were investigated. The WTCCC CNVs were divided into two groups, according to whether they were tagged (*r^2^*≥0.80) by a local (i.e., within 1 MB) SNP from imputed WTCCC1 data and genotyped WTCCC2 data from both the Affymetrix and Illumina arrays (see <http://www.wtccc.org.uk/wtcccplus_cnv/masterCNVlist.final.README.txt>). The third group contains CNVs assayed in HapMap LCLs (Conrad *et al.*) that were determined to be different from those in the WTCCC set.

At an expression p value threshold of 10^−4^, tCNVs from the recently released study (*N* = 3,432) of CNVs in 16,000 cases and 3,000 controls [@pgen.1001292-WTCCC1] were evaluated for their effect on gene expression. We first considered tCNVs that are tagged at *r^2^*≥0.80. The tag SNPs for these CNVs enable SNP-based analyses and simulation studies. We identified 1,714 such SNPs tagging CNVs (corresponding to 1,761 tCNVs), of which 532 are eQTLs at this threshold; collectively, these SNPs tagging CNVs were found to target 2,215 distinct transcripts. Restricting our focus to eQTLs that regulate transcript levels in *cis* (defined as within 4 MB of target transcript), we observed a highly significant *cis* eQTL enrichment (p\<0.001) from a simulation procedure (*N* = 1000) used to empirically generate the null distribution using randomly generated sets of variants of the same set size and matching minor allele frequency distribution as the SNPs tagging CNVs (see [Materials and Methods](#s4){ref-type="sec"}). These SNPs tagging CNVs are significantly more likely to be associated with altered expression of genes in their vicinity than frequency-matched SNPs (see [Figure 1](#pgen-1001292-g001){ref-type="fig"}). Specifically, 24 such SNPs tagging CNVs are acting in *cis*, whereas the expected count is 10.7 (SD = 3.2). On the other hand, the observed count of *trans*-acting eQTLs is 508 while expected count is 488.9 (SD = 17.6).

![SNPs tagging tCNVs are likely to be eQTLs.\
(A) SNPs tagging tCNVs (*r^2^*≥0.80) are enriched for *cis*-acting eQTLs (eQTLs within 4 mb of target transcript). The distribution of the number of *cis*-acting eQTLs (at p\<10^−4^) in 1,000 draws (each of same count as the number of tCNVs) of frequency-matched variants is shown in the bar graphs, with the actual number of *cis*-acting eQTLs observed in the tCNVs from the Wellcome Trust study shown as a solid circle. (B) SNPs tagging tCNVs are more likely to be eQTLs that predict the transcript levels of 10 or more genes than frequency-matched variants.](pgen.1001292.g001){#pgen-1001292-g001}

We identified 621 SNPs tagging CNVs corresponding to 626 tCNVs that are perfectly tagged (*r^2^* = 1.0). Of these 621, 185 predict the expression of at least one transcript, whereas, based on simulations, the expected count is 166.5 (SD = 9.9). This observation implies a statistically significant (p = 0.024) enrichment for eQTLs among this class of CNVs. Restricting our focus to eQTLs that regulate transcript levels locally, we observed 10 such *cis*-acting tCNVs. This observed count is, as before, a significant enrichment (p\<0.001) for *cis*-acting regulators compared with expected count (see [Materials and Methods](#s4){ref-type="sec"}) of 3.5 (SD = 1.9) (see [Figure S1](#pgen.1001292.s001){ref-type="supplementary-material"}).

To determine whether our observations are dependent on the p value threshold used to define an eQTL, we explored evidence of eQTL enrichment among the tCNVs (*r^2^*≥0.80) at p\<10^−6^. Simulations yielded an expected eQTL count of 19.7 (SD = 4.5) whereas observed count is 28, yielding a statistically significant enrichment (p = 0.036). Expected *cis*-acting eQTL count is 1.9 (SD = 1.4) while observed count is 8. These findings demonstrate that the observed enrichment holds robustly at lower expression thresholds. There are 2.5 times as many *trans* eQTLs as *cis* eQTLs among the tCNVs at this threshold.

Using Gene Ontology (GO) enrichment [@pgen.1001292-Huang1], we found the target genes of these expression associated CNVs (eCNVs) to show a highly significant overrepresentation for certain biological processes including immune response (p = 2.3e-4, adjusted p-value 0.034) and regulation of apoptosis (p = 8e-6, adjusted p-value 0.015). Relative to other genic CNVs, the observation on the enrichment of the target genes of eCNVs for response to stimuli continues to hold (p = 9.9e-3, adjusted p-value 0.05).

tCNVs are enriched for eQTL hotspots {#s2b}
------------------------------------

Notably, we identified 22 tCNVs (*r^2^* = 1) that predict the transcript level of 10 or more genes. These CNVs are regulating the expression of distal transcripts. By performing simulations on frequency-matched SNPs as the tCNVs, we observed an enrichment (expected count = 14.7, SD = 3.8) for CNVs controlling the expression of 10 or more, often distal, transcripts (See [Figure S1](#pgen.1001292.s001){ref-type="supplementary-material"}). We identified 2 CNVs *CNVR4596.1* (chrom10:4698559--4700493) and *CNVR1045.1* (chrom2:165722938--165725072) that predict the expression of at least 100 transcripts. *CNVR4596.1* does not contain any genes; on the other hand, *CNVR1045.1* overlaps with *SCN3A*. Additional CNVs *CNVR3307.1* (chrom7:17780194--17781249), *CNVR3500.1* (chrom7:97233946--97240537), and *CNVR7062.1* (chrom17:27130696--27131638) predict the expression of at least 50 transcripts. The CNV region *CNVR3307.1* contains several SNPs (e.g., *rs2723520*, *rs1404418*, and *rs1404419*) in strong LD, which individually predict the expression of more than 80 transcripts.

We identified a CNV (*CNVR2845.27* at chrom6:32710664--32743652) in perfect LD with the replicated type 1 diabetes SNP *rs9272346* predicting the expression of at least 20 transcripts, mostly in the HLA region; a CNV (*CNVR2845.40* at chrom6:32735154--32737954) is tagged (*r^2^* = 0.95) by the same type 1 diabetes SNP. A tCNV *CNVR2845.46* is also in strong LD (*r^2^* = 0.93) with a replicated multiple sclerosis SNP *rs3135388* and predicts the expression of 20 transcripts (of which the *largest* expression association p value is ∼10^−33^).

CNVs harbor a high proportion of regulatory SNPs {#s2c}
------------------------------------------------

Since the deletion/duplication of multiple regulatory SNPs may result in aberrant transcription or disease, we evaluated the presence of SNP eQTLs within CNVs. We identified 33 CNVs harboring 50 or more SNP eQTLs that predict the expression of a transcript ([Table S1](#pgen.1001292.s004){ref-type="supplementary-material"} lists these CNVs based on the number of SNP eQTLs within); these CNVs show an average SNP eQTL density of 6 per 10 kb.

We observed 1,306 CNVs (out of the 3,432 CNVs included in the WTCCC study) containing at least one SNP eQTL. Notably, CNVs that harbor a greater number of SNP eQTLs tend to be less well-tagged; this observation holds robustly after accounting for CNV minor allele frequency, which shows little correlation with the number of SNP eQTLs within the CNV (corr = 0.005). In particular, of the top 100 WTCCC CNVs ranked according to the number of SNP eQTLs within, only 31 are well-tagged (*r^2^*≥0.80) and 56 are tagged at *r^2^*\<0.30.

SCAN: SNP and CNV annotation as eQTLs {#s2d}
-------------------------------------

Given the observed functional relevance of tCNVs as regulatory polymorphisms, we comprehensively and systematically characterized the recent genome-wide survey of CNVs in HapMap lymphoblastoid cell lines (LCLs) for their role in expression. We expanded our SCAN database [@pgen.1001292-Gamazon1], which to date serves results only on expression associated SNPs, to include eQTL mappings of HapMap CNVs to transcriptional expression (assayed by the Affymetrix exon array) in the full set of HapMap CEU (Caucasians from UT, USA) and YRI (Yoruba people from Ibadan, Nigeria) populations (See [Materials and Methods](#s4){ref-type="sec"}). This online catalog of expression associated CNVs (eCNVs), publicly available at <http://www.scandb.org>, should serve as an important resource in helping to inform our understanding of complex traits.

Of the CNVs in HapMap [@pgen.1001292-Conrad1] showing association with a transcript (at p value threshold of 10^−4^) in the CEU and YRI samples, 31.1% and 33.1% respectively are predicting the expression of 5 or more transcripts. This is a much higher proportion than is the case for the well-tagged CNVs in the WTCCC CNV study (12.8%).

Reproducible trait associations are enriched for tCNVs {#s2e}
------------------------------------------------------

Among trait-associated SNPs as represented in the NHGRI catalog, we found a significant overrepresentation (p = 0.01) for tCNVs (*r^2^*≥0.80). [Figure 2](#pgen-1001292-g002){ref-type="fig"} shows the distribution of the number of tag SNPs generated from 1000 random sets of SNPs matching the minor allele frequency of the trait-associated SNPs. [Table 2](#pgen-1001292-t002){ref-type="table"} shows the observed overlap between the trait-associated SNPs and the tCNVs (*r^2^*≥0.80). Enrichment analysis of disease classes shows that the observed tCNV enrichment for reproducible trait associations holds for autoimmune disorders and in quantitative metabolic traits.

![Trait-associated SNPs are significantly enriched for SNPs tagging tCNVs.\
The distribution of the number of SNPs tagging tCNVs in 1,000 draws of SNPs from bins matched for minor allele frequency to the trait-associated SNPs is shown in the bar graphs.](pgen.1001292.g002){#pgen-1001292-g002}
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###### The observed overlap between the NHGRI SNPs and SNPs tagging CNVs (*r^2^*≥0.80).

![](pgen.1001292.t002){#pgen-1001292-t002-2}

  *SNPs tagging CNVs*    *chromosome*   *position*   *NHGRI SNP*   *r^2^ between SNPs*   *CNV (maximal r^2^ with best tag SNP)*                             *trait*
  --------------------- -------------- ------------ ------------- --------------------- ---------------------------------------- -------------------------------------------------------------
  rs11576866                  1          10337019    rs10492972           0.887                      CNVR65.1(0.98)                                   Multiple sclerosis
  rs12191877                  6          31360904    rs10484554             1                       CNVR2841.6(0.90)                              Psoriasis, AIDS progression
  rs1450111                   3         157567524     rs3772255           0.948                      CNVR1591.1(1)                                       Aging traits
  rs2001114                   6         167406568     rs2301436           0.814                      CNVR3164.1(1)                                     Crohn\'s Disease
  rs2410618                   8          19897780     rs2083637             1                      CNVR3814.1(0.998)              Waist circumference and related phenotypes, HDL cholesterol
  rs36149991                  6          32630367     rs3135388             1                      CNVR2845.46(0.94)                                  Multiple sclerosis
  rs6693105                   1         150857287     rs4085613             1                       CNVR358.1(0.956)                                       Psoriasis
  rs7560547                   2         203466161     rs6725887             1                        CNVR1111.1(1)                            Myocardial Infarction (early onset)
  rs9635398                   15         84147059     rs7176093           0.846                      CNVR6495.1(1)                                       Aging traits
  rs4882017                   11         48526758     rs7395662             1                        CNVR5165.1(1)                                      HDL cholesterol
  rs4529687                   1          87386671     rs7553864             1                       CNVR240.1(0.99)                                    Smoking behavior
  rs11249248                  1          25625638    rs10903129           0.967                     CNVR117.1(0.945)                                  Cholesterol, total
  rs11209948                  1          72584492     rs2568958             1                         CNVR217.1(1)                                      Body mass index
  rs9405040                   6          32547371     rs2395185             1                      CNVR2845.14(0.90)                                  Ulcerative colitis
  rs1384601                   12         33606133     rs9300212           0.99                     CNVR5492.1(0.997)                                       Cognitive

Three HLA region CNVs, namely *CNVR2841.20*, *CNVR2845.14*, and *CNVR2845.46*, were recently shown to be associated with Crohn\'s disease, rheumatoid arthritis, and type 1diabetes, respectively [@pgen.1001292-WTCCC1]. Our expression study confirms that the last two of these (tagged at *r^2^*\>0.90) are eQTLs that regulate the expression of multiple genes in this region; in contrast, the first CNV shows no evidence for being an eQTL. A previously identified Crohn\'s disease associated locus *CNVR2647.1* [@pgen.1001292-McCarroll3] on chromosome 5, 22 kb upstream of the *IRGM* gene, is a *trans* eQTL for *SHISA4* (p = 3e-05). Two replicated SNPs associated with HDL cholesterol are tagging (*r^2^*≥0.99) nearby CNVs, *CNVR3814.1* (chrom8:19898924--19899800) and *CNVR5165.1* (chrom11:48557432--48560877). Our study shows that both CNVs are eQTLs, with *CNVR5165.1* targeting, distally, the olfactory receptor gene *OR6J1*. The CNV *CNVR3814.1* is also well-tagged (*r^2^* = 0.913) by a SNP reproducibly associated with triglycerides and is an eQTL targeting *ARF4*, which has been shown, in mice, to be involved in metabolic disorders [@pgen.1001292-Li1].

Discussion {#s3}
==========

Some studies have observed a differential taggability for common CNVs; these loci, it is argued, are less likely to be in strong LD (*r^2^*\>0.8) with flanking markers than are frequency-matched SNPs. Several explanations have been proposed to account for this observed differential taggability, such as lower SNP density in regions near CNVs and the higher mutation rates of certain CNVs (producing greater allelic diversity nearby) than those of SNPs [@pgen.1001292-McCarroll1], [@pgen.1001292-Redon1], [@pgen.1001292-McCarroll4]. This observed difference in the magnitude of LD between CNVs and SNPs relative to LD among SNPs impacts, through its effect on allelic association, our ability to assess the phenotypic influence of CNVs. On the other side of this controversy, the recent genome-wide study of an extensive catalog of CNVs in 16,000 cases of eight common diseases has argued that CNVs are generally well-tagged by SNPs. Indeed, among 2- and 3- class CNVs that passed QC and had MAF\>10%, the study found that nearly 80% were tagged by SNPs at *r^2^*\>0.80. Consequently, replication of association results for CNVs can be conducted in an independent sample set by the use of tag SNPs. In this study, we set out to conduct a study of CNVs by analyzing their effect on gene expression and their association with disease susceptibility and other traits. The CNVs that are well-tagged by SNPs, which we call tCNVs, facilitate SNP-based simulation studies to evaluate enrichment. We proceeded to test whether these CNVs were disproportionately more likely to be functional than frequency-matched SNPs, as trait-associated loci or, under the assumption that few trait-associated polymorphisms are likely to alter the composition of gene products, as eQTLs influencing phenotype by altering gene regulation. Our study found that CNV-tagging SNPs are enriched for *cis* eQTLs, and, furthermore, that reproducible trait associations show an overrepresentation of tCNVs relative to frequency-matched SNPs. While the tagged CNVs are particularly easy to investigate in enrichment studies, we found that the proportion of eQTLs (at p value threshold of 10^−4^) in the non-WTCCC CNVs (39%) is higher than in the well-tagged WTCCC CNVs (30%). Given these strong findings on the functional relevance of CNVs, we created a comprehensive online resource of expression associated CNVs in the HapMap populations to supplement our earlier studies on SNP eQTLs.

CNVs can affect phenotype in several ways [@pgen.1001292-Feuk1]. Genes fully covered by CNVs may contribute to disease through a duplication or deletion event. Copy number variant breakpoints may disrupt the expression of genes that overlap CNVs. On the other hand, we have identified two CNVs at considerable distance (in *trans*) from their targets controlling transcript abundance as potential master regulators. Another CNV contains multiple regulatory elements which are each predicting the expression of at least 80 transcripts; the deletion of such important regulatory elements is likely to profoundly alter gene transcription. Importantly, we observed that 1,306 CNVs (out of the 3,432 CNVs included in the WTCCC study) harbor at least one SNP eQTL (defined at p value threshold of 10^−4^). Given our earlier observation that tCNVs are enriched for expression-associated CNVs (eCNVs), it is interesting to ask whether those CNVs not well-tagged by SNPs have interesting properties with respect to gene regulation. Of the CNVs that are tagged at *r^2^*\<0.30, 44% harbor SNP eQTLs.

Previous studies [@pgen.1001292-Conrad1], [@pgen.1001292-McCarroll4], [@pgen.1001292-Feuk1] have reported that genes that undergo dosage differences due to the presence (proximity) of CNVs show an enrichment for genes involved in immune response and response to external biotic stimuli. We identified an olfactory receptor gene *OR6J1* and a gene *DAD1* (defender against cell death 1), both on chromosome 14, that are *trans*-regulated genes for the tCNV *CNVR5165.1* on chromosome 11. We found an overrepresentation for target genes involved in the calibrated molecular response to stimulus (whether chemical stimulus or potential internal or invasive threat). Our novel observation in this regard is that previously reported enrichment for genes relevant for molecular-environmental interactions generalizes to the target genes for tCNVs as eCNVs.

The recent WTCCC CNV study concluded that common CNVs that can be typed on existing platforms are unlikely to have a major role in the genetic basis of complex diseases [@pgen.1001292-WTCCC1]. The same study reported that there was no enrichment of association signals among CNVs involving exonic deletions. Our findings recommend caution in assessments of the contribution of CNVs to the genetics of complex traits. Even under the assumption that most common CNVs are well tagged by SNPs and therefore interrogated by existing SNP GWAS, reproducible trait associations are enriched for these CNVs compared to random expectation. The prominence of such CNVs among reproducible trait associations with autoimmune disorders and metabolic traits suggests that these variants may indeed contribute to certain disease classes; alternatively, they may act in conjunction with other variants such as SNPs to confer susceptibility. Importantly, these CNVs are disproportionately more likely to predict transcript levels than frequency-matched SNPs, and they are more likely to affect many different gene expression traits as master regulatory polymorphisms. An important issue to address is whether the enrichment of tCNVs as eQTLs and as disease-associated SNPs are correlated. Note that the probability that a random SNP is found in the NHGRI catalog increases from 0.062% in the set of HapMap SNPs to about 0.5% (more than 5-fold) in the set of well-tagged CNVs that are not eQTLs and to 2% in the tCNVs that are eQTLs.

It should be noted that the WTCCC CNVs included in our study reflect certain limitations. Indeed, as the WTCCC study itself explicitly noted [@pgen.1001292-WTCCC1], a large proportion (nearly 60%) of the candidate list of putative CNVs could not be reliably assigned copy number classes from the combination of experimental assay and analytical approaches; it is estimated that only about half of these are not polymorphic [@pgen.1001292-WTCCC1]. Particularly, nearly 6,500 such putative polymorphisms were excluded from subsequent analyses, as they were called with a single copy number class. It is of course possible that our conclusions may not generalize to these CNVs. Furthermore, eQTL mapping in microarray-based studies in LCLs is likely to yield only a subset of the eQTLs that will be identified using more refined methods in a variety of human tissues. The present study also has little conclusive to say about low frequency variants. Despite these current limitations, the annotation system we implemented in SCAN should prove useful to other investigators and seeks to be as comprehensive as possible by providing functional information for the most extensive map of CNVs to date from the recent population-based genome-wide survey [@pgen.1001292-Conrad1]. Since the MAF spectrum of the NHGRI catalog of trait-associated SNPs from published GWAS is quite different from that of the SNPs on the genotyping platforms used to conduct these GWAS, we performed our enrichment analyses while conditioning on the MAF distribution. There are other potential representational biases in the NHGRI catalog of reported variants that may have affected our studies. The enrichment in disease classes relative to other classes of traits, for example, may be the result of increased power (e.g., due to greater sample sizes) for these categories.

Since gene expression is intermediate to other complex phenotypes, a global view of the influence of CNVs on the transcriptome may lead to a better understanding of their role in disease susceptibility. While we identified, as perhaps expected, CNVs located in the HLA region associated with multiple expression phenotypes and with various autoimmune disorders, we also observed, strikingly, several non-HLA CNVs that regulate multiple transcripts, including 2 (one on chromosome 10 and the other on chromosome 2) associated with more than 100 expression traits. Using the most extensive population-based CNV map available [@pgen.1001292-Conrad1], we observed a greater proportion of master regulatory CNVs than observed among the well-tagged CNVs. Collectively, all these findings reinforce the importance of considering all types of variation to elucidate the genetic architecture of complex traits.

Materials and Methods {#s4}
=====================

Gene expression dataset using Affymetrix Exon Array {#s4a}
---------------------------------------------------

The mRNA expression was assayed in HapMap lymphoblastoid cell lines (LCLs) in 87 CEU and 89 YRI using the Affymetrix GeneChip Human Exon 1.0 ST Array [@pgen.1001292-Zhang1]. This dataset is available in the public repository Gene Expression Omnibus (Accession No: GSE9703). Measurements on the exon array are done both at the exon-level and at the gene-level. The exon array includes 1.4 million probesets and profiles nearly 13,000 transcript clusters. The transcript clusters include a set of probesets containing all known exons and 5′ and 3′ UTR regions in the genome so that probes interrogate entire gene regions and not just 3′ UTRs (in contrast to other arrays).

SCAN: A database of eQTL SNPs and CNVs {#s4b}
--------------------------------------

The results of our eQTL studies, previously on single base polymorphisms [@pgen.1001292-Nicolae1], [@pgen.1001292-Duan1], [@pgen.1001292-Zhang1], in HapMap LCLs have been made publicly available in an online database SCAN [@pgen.1001292-Gamazon1]. To evaluate the influence of CNVs on the transcriptome, we performed linear regression on over 13,000 transcript clusters with reliable expression -- namely, the log2 transformed normalized expression intensity is greater than 6 for at least 80% of the samples -- and the CNVs assayed in HapMap LCLs. We downloaded genotype information for these CNVs from the recently released reference catalog of HapMap CNVs [@pgen.1001292-Conrad1]. All eQTL analyses were done in both CEU and YRI samples. We extended the SCAN database to include a catalog of expression-associated CNVs in the HapMap populations.

NHGRI database of trait-associated SNPs {#s4c}
---------------------------------------

The National Human Genome Research Institute (NHGRI) curates the results of published GWAS and makes them publicly available in an online catalog of SNP-trait associations. This catalog provides a useful resource for the investigation of genomic characteristics of trait-associated SNPs and of the role of common variants in common disease etiology [@pgen.1001292-Hindorff1]. The version we utilized for our present study was retrieved on June 29, 2009. SNP-trait associations included in the catalog are those with p values\<1.0×10^−5^, and generally only one SNP within a gene or a high LD region is included unless there is evidence of an independent association. To evaluate whether our observation on the significant enrichment among tagged CNVs for trait-associated SNPs is driven by certain traits or disease classes, we considered separately various disease types, including neuropsychiatric disorders, cancers, and autoimmune disorders.

Simulation studies {#s4d}
------------------

We conducted simulations to evaluate enrichment for eQTLs among the tCNVs included in our study. To empirically generate the null distribution of no enrichment, we randomly generated sets of SNPs of matching minor allele frequency as the original list of SNPs tagging the tCNVs, as previously described [@pgen.1001292-Nicolae1]. To enable us to perform simulations conditional on MAF, we constructed non-overlapping MAF bins, each of width 0.05, using the MAFs of the SNPs in the HapMap CEU samples. The null sets were drawn from the combined platform SNPs (Affymetrix 6.0 and Illumina 1M) as well as from the entire set of HapMap CEU SNPs. The observed count is then compared to the empirically generated distribution to get an empirical p value for the enrichment.

A catalog of Wellcome Trust CNVs {#s4e}
--------------------------------

A survey of 3,432 WTCCC CNVs [@pgen.1001292-WTCCC1] shows that their minor allele frequency distribution differs markedly from the distribution of reproducible trait-associated SNPs as represented in the NGHRI catalog (See [Figure S2](#pgen.1001292.s002){ref-type="supplementary-material"}). Of these, nearly 80% with minor allele frequency at least 10% are well tagged (*r^2^*≥0.8). Roughly 89% of the tagged CNVs (*r^2^*≥0.8) are less than 10 kb in length, and 26% are less than 1 kb long (See ). [Table S2](#pgen.1001292.s005){ref-type="supplementary-material"} shows the median length (in log10) of the WTCCC CNVs.

The 3,432 CNVs included in this study passed the WTCCC quality control filters out of the 4,326 that were called with multiple classes [@pgen.1001292-WTCCC1].

Supporting Information {#s5}
======================

###### 

\(A\) SNPs perfectly tagging CNVs (i.e., r2 = 1.0) are enriched for eQTLs that regulate transcript levels in cis. The distribution of the number of cis-acting eQTLs (at p\<10−4) in 1,000 draws (each of same count as the number of tCNVs) of frequency-matched SNPs is shown in the bar graphs, with the actual number of eQTLs observed in the tCNVs from the Wellcome Trust study shown as a solid circle. (B) SNPs perfectly tagging CNVs (i.e., r2 = 1.0) are more likely to be eQTLs that predict the transcript levels of 10 or more genes than frequency-matched SNPs.

(3.62 MB TIF)

###### 

Click here for additional data file.

###### 

The minor allele frequency distribution of the CNVs from the WTCCC survey is shown. Their minor allele frequency distribution differs markedly from the distribution of reproducible trait-associated SNPs from the NHGRI catalog.

(1.35 MB TIF)

###### 

Click here for additional data file.

###### 

The size distribution of the CNVs from the WTCCC study is shown. CNV length ranges from 0.446 kb to 662 kb with average 14 kb.

(1.22 MB TIF)
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Click here for additional data file.

###### 

We identified 33 CNVs harboring 50 or more SNP eQTLs that predict the expression of a transcript.

(0.02 MB XLS)

###### 

Click here for additional data file.

###### 

The length of the different categories of CNVs evaluated in our study.

(0.02 MB XLS)

###### 

Click here for additional data file.

We acknowledge the Wellcome Trust Case Control Consortium for making available data about SNP tagging of common CNVs (<http://www.wtccc.org.uk/wtcccplus_cnv/supplemental.shtml>).

The authors have declared that no competing interests exist.

This work was funded through PAAR (Pharmacogenetics of Anti-Cancer Agents Research; U01 GM61393), ENDGAMe (ENhancing Development of Genome-Wide Association Methods) initiative (U01 HL084715), the Genotype-Tissue Expression project (GTeX) (R01 MH090937), The University of Chicago Breast Cancer SPORE (P50 CA125183), and The University Of Chicago DRTC (Diabetes Research and Training Center; P60 DK20595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[^1]: Conceived and designed the experiments: ERG DLN NJC. Performed the experiments: ERG. Analyzed the data: ERG DLN NJC. Contributed reagents/materials/analysis tools: ERG. Wrote the paper: ERG DLN NJC.
